NATUS MEDICAL INC (NTUS) Stock Analyst Earnings Estimates
NASDAQ:NTUS - Nasdaq - US6390501038 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 495.2M -6.72% | 415.7M -16.05% | 473.44M 13.89% | 504.9M 6.64% | 527.544M 4.48% | 541.975M 2.74% | 567.937M 4.79% | |
| EBITDA YoY % growth | 59.72M 28.54% | 18.12M -69.66% | 57.47M 217.16% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 29M 130.16% | -10M -134.48% | 29.38M 393.80% | 66.912M 127.75% | 73.338M 9.60% | 179.75M 145.10% | 449.375M 150.00% | |
| Operating Margin | 5.86% | -2.41% | 6.21% | 13.25% | 13.90% | 33.17% | 79.12% | |
| EPS YoY % growth | 1.25 -11.97% | 0.39 -68.80% | 1.20 207.69% | 1.47 22.40% | 1.60 9.03% | 1.84 14.83% | 2.15 17.12% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 12.55% | 0.38 34.79% | 0.50 6.34% | 0.35 57.64% | 0.36 9.37% | 0.40 5.41% | 0.50 |
| Revenue Q2Q % growth | 122.808M 5.89% | 126.174M 10.80% | 137.904M 7.18% | 124.134M 3.63% | 128.724M 4.82% | 130.458M 3.40% | 144.126M 4.51% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 14.892M 142.94% | 17.136M 123.13% | 22.44M 63.44% | 15.81M 153.77% | 16.32M 9.59% | 18.156M 5.95% | 23.052M 2.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 0.22 37.50% | 0.27 | -0.05 | -17.04% |
| Q4 2021 Q2Q % growth | 0.47 20.51% | 0.45 | 0.02 | 4.72% |
| Q3 2021 Q2Q % growth | 0.28 211.11% | 0.35 | -0.07 | -19.26% |
| Q2 2021 Q2Q % growth | 0.29 323.08% | 0.26 | 0.03 | 13.73% |
| Q1 2021 Q2Q % growth | 0.16 300.00% | 0.16 | 0.00 | -1.96% |
| Q4 2020 Q2Q % growth | 0.39 -15.22% | 0.24 | 0.15 | 59.31% |
| Q3 2020 Q2Q % growth | 0.09 -75.00% | 0.01 | 0.08 | 782.35% |
| Q2 2020 Q2Q % growth | -0.13 -138.24% | 0.05 | -0.18 | -354.90% |
| Q1 2020 Q2Q % growth | 0.04 -55.56% | 0.22 | -0.18 | -82.17% |
| Q4 2019 Q2Q % growth | 0.46 | 0.48 | -0.02 | -4.05% |
| Q3 2019 Q2Q % growth | 0.36 | 0.38 | -0.02 | -5.88% |
| Q2 2019 Q2Q % growth | 0.34 | 0.31 | 0.03 | 11.11% |
| Q1 2019 Q2Q % growth | 0.09 | 0.06 | 0.03 | 60.43% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 119.79M 4.26% | 118.014M | 1.776M | 1.50% |
| Q4 2021 Q2Q % growth | 128.66M 8.39% | 125.352M | 3.308M | 2.64% |
| Q3 2021 Q2Q % growth | 113.88M 10.78% | 118.552M | -4.672M | -3.94% |
| Q2 2021 Q2Q % growth | 115.98M 36.77% | 116.28M | -300K | -0.26% |
| Q1 2021 Q2Q % growth | 114.9M 5.03% | 113.628M | 1.272M | 1.12% |
| Q4 2020 Q2Q % growth | 118.7M -9.67% | 112.2M | 6.5M | 5.79% |
| Q3 2020 Q2Q % growth | 102.8M -16.76% | 96.288M | 6.512M | 6.76% |
| Q2 2020 Q2Q % growth | 84.8M -32.43% | 100.164M | -15.364M | -15.34% |
| Q1 2020 Q2Q % growth | 109.4M -4.70% | 117.3M | -7.9M | -6.73% |
| Q4 2019 Q2Q % growth | 131.4M | 132.6M | -1.2M | -0.90% |
| Q3 2019 Q2Q % growth | 123.5M | 127.245M | -3.745M | -2.94% |
| Q2 2019 Q2Q % growth | 125.5M | 125.307M | 193K | 0.15% |
| Q1 2019 Q2Q % growth | 114.8M | 115.567M | -767.02K | -0.66% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |